🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The receptor tyrosine kinase AXL is a pathway that plays a crucial role in ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-06-30
Trial ID
NCT03607955
The purpose of this research study is to test the safety of avelumab and AV...
Status
Active Not Recruiting
Location
Stephenson Cancer Center
Start Date
2020-02-17
Trial ID
NCT04004442
Treatments Being Tested
This is a randomized single-blind, placebo-controlled, Phase 1, single asce...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2018-01-31
Trial ID
NCT03401528
Treatments Being Tested
This is a Phase 1b/2 study of AVB-S6-500 designed to evaluate the safety an...
Status
Terminated
Location
University of Maryland Greenebaum Comprehensive Cancer Center
Start Date
2021-02-26
Trial ID
NCT04300140
Treatments Being Tested
This is a randomized, double-blind Phase 3 study to compare the efficacy an...
Status
Terminated
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2021-04-22
Trial ID
NCT04729608
Treatments Being Tested
The purpose of this study is to determine safety and tolerability of AVB-50...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-31
Trial ID
NCT05826015
Treatments Being Tested
This is a Phase 1b/2 study of AVB-S6-500 in combination with pegylated lipo...
Status
Completed
Location
Arizona Oncology
Start Date
2018-12-06
Trial ID
NCT03639246
Treatments Being Tested
This is an open-label Phase 2a clinical study designed to evaluate the safe...
Status
Terminated
Location
Moonshine Clinical Research
Start Date
2019-11-27
Trial ID
NCT04042623
Treatments Being Tested
This trial studies the side effects and best dose of AVB-S6-500 when given ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-12-03
Trial ID
NCT04019288
Treatments Being Tested
This is a Phase 1b/2 study of batiraxcept (AVB-S6-500) designed to evaluate...
Status
Terminated
Location
UCLA Health
Start Date
2021-07-28
Trial ID
NCT04983407
Treatments Being Tested